NXG.V · NexgenRx Inc.
Canada · RS rating 95 · As of 2026-10-14
| Price | 0.62 CAD |
|---|---|
| 1-day change | +3.3% |
| RS rating (overall / 1M / 3M / 12M) | 95 / 76 / 87 / 86 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 48 / 77 / 40 |
| Industry group (rank) | Computer Sftwr-Medical (73) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +3.3% |
| Distance from 52-week high | +11.4% |
| Market cap (USD) | $30.0M |